Adaptive trials allow for modifications to be made during the trial without requiring additional approvals. According to the ...

The green light in the US is the first worldwide for Enflonsia ( clesrovimab) and makes the long-acting antibody the first ...

Asked where AI is having the biggest impact in digital engagement, around half (49%) of respondents said it was in data ...

Health and Human Services (HHS) Secretary Robert F Kennedy Jr has removed all 17 members of the CDC's Advisory Committee on ...

The green light in the US is the first worldwide for Enflonsia ( clesrovimab) and makes the long-acting antibody the first ...

NewAmsterdam Pharma has said that an oral drug it is developing to lower cholesterol has shown preliminary efficacy as a ...

Currently available PCSK9-targeting therapies are Amgen's Repatha (evolocumab) and Sanofi/Regeneron's Praluent (alirocumab), ...

AbbVie presented new data from its novel antibody-drug conjugates (ADCs) at ASCO 2025, including telisotuzumab adizutecan ...

Going into 2025, we expect pharma brands and their advertising partners to use past learnings – and, more importantly – ...

Europe follows a similar pattern, with data from the EU Clinical Trials Information System (CTIS) estimating that less than 0 ...

Changing a cultural undertow is one of the hardest leadership challenges in any industry, and perhaps even more so in the ...

UK start-up George Medicines has brought its triple therapy for high blood pressure over the finish line, with an FDA ...